JOINT FILING AGREEMENTJoint Filing Agreement • August 20th, 2021 • Lind Global Fund II LP • Pharmaceutical preparations
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of EyeGate Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
